JPRN-UMIN000002600已完成未知
Effects of HMG-CoA reductase inhibitor on atherosclerosis and multi-lipoprotein profiling in patients without coronary artery disease - Statin therapy against multi-lipoprotein profiling and atherosclerosis -Primary- (SAMURAI Study - Primary -)
agoya University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2009年10月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have taken statins. 2) Patients who have suffered from acute myocardial infarction for the past 3 months. 3) Patients undergoing CABG or PCI for the past 3 months, or planning CABG or PCIin the study periods. 4) Patients with active malignant tumor. 5) Patients with severe renal dysfunction. 6) Patients with severe hepatic dysfunction. 7) Patients with collagen disease. 8) Patients during pregnancy and nursing. 9) Patients who do not accept informed consent. 10) Patients judged as being inappropriate for this study by investigators.
研究者
相似试验
进行中（未招募）
1 期
Effect of HMG-Co A reductase inhibition on endothelial dysfunction, bioavailability of tetrahydrobiopterin (BH4) and functional regulation of endothelial nitric oxide synthase (eNOS) in human heart failure. - Effect of statins on functional regulation of eNOS in heart failure.Heart failureEUCTR2008-002287-33-GBBelfast Health and Social Care Trust60
进行中（未招募）
1 期
Effects of HMG-CoA-reductase inhibition (atorvastatin) on renal sodium excretion, renal hemodynamics, tubular function and vasoactive hormones in healthy subjects under diet with normal and high sodium content.EUCTR2006-005143-28-DKMedicinsk Forskning
已完成
不适用
Renoprotective effects of HMG/CoA reductase inhibitor on patients with hyperlipidemia associated with renal insufficiency-Effect of atorvastatin by switching from other statinsDiabetes MellitusJPRN-UMIN000007703Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital30
已完成
4 期
Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on AtherosclerosisAtherosclerosisNCT00560170National Cheng-Kung University Hospital40
已完成
不适用
The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 SecretionHydroxymethylglutaryl-CoA Reductase InhibitorsDiabetes Mellitus, Type 2NCT03018444University Hospital, Gentofte, Copenhagen15